key: cord-0914435-latu2yr3
authors: Bohan, Dana; Van Ert, Hanora; Ruggio, Natalie; Rogers, Kai J.; Badreddine, Mohammad; Aguilar Briseño, José A.; Chavez, Roberth Anthony Rojas; Gao, Boning; Stokowy, Tomasz; Christakou, Eleni; Micklem, David; Gausdal, Gro; Haim, Hillel; Minna, John; Lorens, James B.; Maury, Wendy
title: Phosphatidylserine Receptors Enhance SARS-CoV-2 Infection: AXL as a Therapeutic Target for COVID-19
date: 2021-06-24
journal: bioRxiv
DOI: 10.1101/2021.06.15.448419
sha: bbb4fb90a73cca9c19824f8ad3eec2c75dac5555
doc_id: 914435
cord_uid: latu2yr3

Phosphatidylserine (PS) receptors are PS binding proteins that mediate uptake of apoptotic bodies. Many enveloped viruses utilize this PS/PS receptor mechanism to adhere to and internalize into the endosomal compartment of cells and this is termed apoptotic mimicry. For viruses that have a mechanism(s) of endosomal escape, apoptotic mimicry is a productive route of virus entry. We evaluated if PS receptors serve as cell surface receptors for SARS-CoV-2 and found that the PS receptors, AXL, TIM-1 and TIM-4, facilitated virus infection when low concentrations of the SARS-CoV-2 cognate receptor, ACE2, was present. Consistent with the established mechanism of PS receptor utilization by other viruses, PS liposomes competed with SARS-CoV-2 for binding and entry. We demonstrated that this PS receptor enhances SARS-CoV-2 binding to and infection of an array of human lung cell lines and is an under-appreciated but potentially important host factor facilitating SARS-CoV-2 entry.

receptors in SARS-CoV-2 entry, we observed enhanced virion attachment to cells when PS 1 0 7 receptors were expressed (Fig. 1D) . In addition to viral load assessments, supernatants from 1 0 8 SARS-CoV-2 infected HEK 293T cultures were evaluated for production of infectious virions at 1 0 9 48 hpi by TCID 50 assays in Vero E6 cells that express TMPRSS2. Low levels (50 ng) of ACE2 1 1 0 transfection increased virion production and this was enhanced by co-expression of TIM-1 ( A previous study concluded that the related coronavirus, SARS-CoV, was not productively 3 4 6 internalized by PS receptors (11). However, with insights from our studies, an alternative 3 4 7 explanation is that PS receptor enhancement of coronavirus entry is ACE2-dependent and 3 4 8 sufficient quantities of ACE2 on the plasma membrane abrogate a role for PS receptors. Thus, 3 4 9 PS receptors only facilitate SARS-CoV-2 entry under conditions where ACE2 is expressed at 3 5 0 suboptimal levels, conditions that were likely not evaluated in the cited study but are found on 3 5 1 ACE2 expressing cells such as Vero E6 cells and many patient derived lung cell lines. As ACE2 3 5 2 expression is low within the lung, such suboptimal conditions may be highly relevant during Our studies provide evidence that PS receptors enhance SARS-CoV-2 binding to cells and 3 6 4 mediate internalization into endosomes where cysteine proteases potentiate spike protein 3 6 5 triggering and subsequent fusion events. Consistent with the utilization of this uptake pathway, 3 6 6 the cysteine protease inhibitor E-64 effectively blocked ACE2 or ACE2/PS receptor entry in HEK 3 6 7 293T cells. This is also supported by our super resolution microscopy observations that AXL 3 6 8 and ACE2 colocalize during SARS-CoV-2 infection. However, in HEK 293T, the route of virus 3 6 9 entry changes upon expression of TMPRSS2; virion entry is no longer sensitive to E-64. As 3 7 0 others have reported, these findings are consistent with TMPRSS2-dependent entry dominating 3 7 1 as the route of entry when TMPRSS2 is expressed (24, 42, 43) . We also investigated virus 3 7 2 infection of a variety of lung lines that endogenously express TMPRSS2, AXL, and ACE2. While 3 7 3 findings with Calu-3 cells were similar to that we observed in TMPRSS2-transfected HEK 293T 3 7 4 cells, the other TMPRSS2 + lung lines, such as H1650 cells, remained sensitive to E-64 and the 3 7 5 AXL signaling inhibitor, bemcentinib. Differences in the ability of TMPRSS2 expression to 3 7 6 control the route of entry may be due to a fine balance of surface expression of the various 3 7 7 receptors and should be explored in more detail. Our data indicate that AXL serves as the most important PS receptor for SARS-CoV-2 infection 3 8 0 of the TIM and TAM families and our studies with MHV implicated AXL in facilitating infection of 3 8 1 additional coronaviruses. While AXL is abundant on lung epithelial cells, it is also present in 3 8 2 many organs in the body, with the exclusion of neural tissues (32, 44). Thus, it is likely a role for 3 8 3 AXL in SARS-CoV-2 infection is not only relevant to lung cell populations, but ACE2-expressing 3 8 4 tissues suspected to be affected by COVID-19 such as the heart and kidneys (45, 46). We 3 8 5 surmise that AXL-inhibiting therapeutics could function in tandem with other antivirals, protecting 3 8 6 a number of organs from infection. Our data suggest that the efficacy of bemcentinib will persist 3 8 7 as the virus evolves, inhibiting the VOCs Alpha and Beta effectively. By targeting host proteins

The preferential utilization of AXL rather than TIM-1 by SARS-CoV-2 in Vero E6 cells was 3 9 5 unexpected. In our previously studies, other enveloped viruses that utilize PS receptors, such as 3 9 6 filoviruses, use TIM-1 preferentially when both proteins are expressed (12, 20) . Further, a recent 3 9 7 study identified that the TIM-1 IgV domain that contains the PS binding pocket serves as an DNA transfection along with PEI (1 mg/mL) at a concentration of 3 µl/ 1 µg of DNA transfected.

Tubes were combined, vortexed vigorously for 10-15 seconds and incubated at room 5 6 4 temperature for 15 minutes. Mixtures were added dropwise to HEK 293T cells. For all 5 6 5 experiments using ACE2 50 ng of ACE2 plasmid were transfected, unless otherwise noted. For 5 6 6 PS receptors, 1000ng of plasmid was transfected unless otherwise noted. All transfections were 5 6 7 brought up to 2 µg total transfected DNA with a PCD3.1 empty expression vector. Following PEI transfection with plasmids as described in the previous section, cells were lifted 6 1 9 with 0.25% trypsin and plated into 48-well plates at a density of 6 x 10 4 (Dot Scientific; Ref# 6 2 0 667148). In our BSL3 facility, transfected HEK 293T cells were infected at a MOI = 0.5 with 6 2 1 SARS-CoV-2. Cells were incubated at 37°C or 24 hours and then treated with TRIzol RNA 6 2 2 isolation reagent and removed from the BSL3 facility. RNA extraction and cDNA generation 6 2 3 proceeded as described. qRT-PCR was conducted on the cDNA using SARS-CoV-2-Spike and 6 2 4 GAPDH primers. Data analyzed using the ∆ ∆ Ct method as described above. The NTD-Fc and RBD-Fc constructs were kindly provided by Tom Gallagher. They contain the 6 5 6

Fc region of human IgG1 fused to the N-terminal domain of SARS-CoV-2 Spike (residues 1-6 5 7 309) or the RBD-containing C-terminal domain of the S1 subunit (residues 310-529). We also 6 5 8 generated an Fc-Spike construct that contains the Fc region of human IgG1 fused to a 6 5 9

cleavage-negative form of the Spike ectodomain (subunits S1 and S2, corresponding to ProCDM and purified using Protein A beads. Eluted products were dialyzed against phosphate 6 6 4 buffered saline (pH 7.4). All proteins were analyzed by SDS-PAGE and gels were silver stained 6 6 5 to verify the purity of the eluted product. 6 6 6 6 6 7

We measured the binding efficiency of anti-NTD antibody AM121 (Acro Biosystems) to the 6 6 8

Spike-based constructs using an enzyme-linked immunosorbent assay (ELISA), as previously 

Luminescence fold change were compared to mock transfected lysates that were set to a value 8 2 1 of 1. D) AXL is unable to directly interact with purified, soluble SARS-CoV-2 spike/Fc. HEK 293T 8 2 2 cells transfected with AXL or ACE2 were incubated with soluble spike protein (S1/S2)-Fc, S1 8 2 3 RBD-Fc or S1 NTD-Fc and subsequently incubated with an Alexa 647 secondary. Spike protein 

Luciferase activity was determined 24 hpi. student's t-test (B, C, F, H); asterisks represent p < 0.05. 8 6 8

CoV-2 infection is reduced by AXL inhibition in multiple human lung cell lines. In order: 

interfere with SARS-CoV-2 pseudovirion entry. Vero E6 cells were treated with PS or PC liposomes and incubated with VSV-GFP/Spike pseudovirions for 24 hours. Entry was detected by GFP fluorescence. B) PS liposomes disrupt SARS-CoV-2 binding. Vero E6 cells were incubated with SARS-CoV-2 (MOI = 5) at 10°C for 1 hour, washed extensively, and viral load assessed by RT-qPCR. C) AXL signaling inhibitor bemcentinib inhibits SARS-CoV-2 infection in Vero E6 cells. Cells were treated with bemcentinib and infected with SARS-CoV-2 (MOI = 0.01). Viral loads were measured 24 hpi by RT-qPCR. D) Bemcentinib inhibition of SARS-CoV-2 infection is most efficacious at early time points during infection. Vero E6 cells were challenged with SARS-CoV-2 (MOI = 0.01) and treated with either the vehicle control or 1 μM bemcentinib at the indicated time. Viral loads were measured 24 hpi by RT-qPCR. E) Vero E6 cells were treated with 1 μM bemcentinib, infected with SARS-CoV-2 (MOI = 0.01) and mRNA harvested 18 hpi. mRNA was deep sequenced on an Illumina platform, and viral loads were calculated by alignment to the SARS-CoV-2 genome. F) Broad spectrum TAM inhibitor BMS-777607 inhibits SARS-CoV-2 infection in Vero E6 cells. Cells were treated with inhibitor at indicated concentrations for 1 hour, challenged (MOI = 0.01), and viral loads measured 24 hpi by RT-qPCR G) STED micrographs showing staining for ACE2 (red) and AXL (green) and merged in Vero E6 cells. Insets are enlarged images from regions highlighted by yellow rectangles.

White arrows indicate shared vesicular structures between the two channels. Yellow arrowheads indicate objects that are only seen in one channel. Plot profiles are shown in S4F, representing signal intensity along the yellow lines in the merged panels. H) Pearson's correlation coefficients of ACE2 and AXL were calculated for n=20 mock and infected cells (ROI determined by cell borders).

Data are pooled from at least 3 independent experiments (B, D, F) or are representative of at least 3 experiments (A, C, G, H). Data are represented as means ± SEM. Multiple t-tests (A) student's t-test (B, C, F, H); asterisks represent p < 0.05.

-2 infection is reduced by AXL inhibition in multiple human lung cell lines. In order: A549 ACE2 , H1650, HCC1944, H1819, HCC2302, Calu3 were treated with the indicated inhibitors for 1 hour and challenged with SARS-CoV-2 (MOI = 0.5) for 24 hours. Viral load was assessed by RT-qPCR. G) HCC2302 cells were treated with bemcentinib at the indicated concentrations for 1 hour and infected with SARS-CoV-2 (MOI = 0.5). Input virus was removed 6 hpi and supernatant was collected at 24 and 48 hpi and titered by TCID 50 assays on Vero E6-TMPRSS2 cells. TCID 50 /mL was calculated by the Spearmann-Karber method. H) A549 ACE2 were treated with bemcentinib as indicated, infected with SARS-CoV-2 (MOI = 0.5) and mRNA harvested 24 hpi. mRNA was sequenced, and viral loads calculated by alignment to the SARS-CoV-2 genome.

Data are pooled from at least 3 independent experiments (F) or are representative of at least 3 experiments (A, B, C, D, E, G). Data represented as means ± SEM. Student's t-test; asterisks represent p < 0.05. 

AXL is a candidate receptor for 39

The lipid membrane

isolation of the H1650 AXL neg clone. 13.

H1650 AXL knockout cells were generated by lentiviral transduction of Cas9 and gRNA targeting AXL, followed by selection, enrichment, and biological cloning. Shown are flow cytometry histograms depicting AXL surface staining (black) and secondary only background (grey), demonstrating loss of AXL expression. B) H1650 AXL neg and H1650 Cas9 (parental) lines were challenged with SARS-CoV-2 at indicated MOIs. At 24hpi, viral loads were assessed by RT-qPCR. C) H1650 parental and AXL neg lines were treated with indicated concentration of bemcentinib for 1 hour and subsequently challenged with SARS-CoV-2 (MOI = 0.5) and viral loads determine by RT-qPCR 24 hpi. Data are pooled from at least 3 independent experiments (B, C) or are representative of at least 3 experiments (A). Data represented as means ± SEM. Multiple t-tests; asterisks represent p < 0.05.